{"database": "lobbying", "table": "lobbying_activities", "rows": [[3054717, "ac551ec4-8c32-48f5-a455-8727c7641269", "Q3", "PORT SIDE STRATEGIES, LLC", 401105394, "NEW VENTURE FUND", 2023, "third_quarter", "PHA", "Issues related to implementation of the drug pricing provisions of the Inflation Reduction Act of 2022. S.2305 - Biosimilar Red Tape Elimination Act - in support. S. 2157 - A bill to repeal prescription drug price control provisions of the Inflation Reduction Act - opposed. H.R.4895 - Lowering Drug Costs for American Families Act - in support.", "HOUSE OF REPRESENTATIVES,SENATE,White House Office", null, null, 0, 0, "2023-10-17T21:07:22-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3054717"], "units": {}, "query_ms": 2.192474086768925, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}